Nan Fung Trinity (Hk) LTD Trevi Therapeutics, Inc. Put Options Transaction History
Nan Fung Trinity (Hk) LTD
- $910 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TRVI
# of Institutions
170Shares Held
111MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$143 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$111 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$92.1 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$57.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$48.4 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $629M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...